Skip to main content

Topic

Insulin Access

17 published works

  1. Hall Benefits Law Blog

    Oregon Sues Drug Companies and PBMs Over High Insulin Prices

    By Anne Hall

    The state of Oregon has filed a $900 million lawsuit against American insulin manufacturers and pharmacy benefit managers (PBMs). According to the lawsuit, drug manufacturers and PBMs colluded in violation…

  2. Hall Benefits Law Blog

    Indiana Sues Eli Lilly Over Skyrocketing Insulin Prices

    By Anne Hall

    The state of Indiana has filed suit against Indiana-based drug manufacturer Eli Lilly and Co. for conspiring with other manufacturers and pharmacy benefit managers (PBMs) to artificially inflate insulin prices…

  3. Drug & Device Law

    First Circuit Approves Federal Officer Jurisdiction In Insulin Pricing Row

    By Steven Boranian

    Federal officer jurisdiction is the quiet middle child of the federal jurisdiction family.  We all came out of law school fully versed in federal question jurisdiction and diversity jurisdiction (and…

  4. Health Law Prof Blog

    A Competition Law Approach to Accessing Insulin

    By Katharine Van Tassel

    Frederick M. Abbott (Florida State University), Padmashree Gehl Sampath (Harvard University), A Competition Law Approach to Accessing Insulin (Working Paper, United Nations Dev. Programme (2022):The World Health Organization (WHO) estimates…

  5. State AG Blog

    State AG Updates: November 16-29, 2023

    By Toni Michelle Jackson, Anna Kufta

    Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. Here are this week’s updates. Multistate The New York Attorney General Letitia James…

  6. Napoli Shkolnik Blog

    Lawsuit Filed Insulin Pricing Scheme Complaint on Behalf of Cattaraugus County, NY Against 19 Major Players in Pharma Industry

    By Napoli Shkolnik PLLC

    Complaint Claims Opaque, Conspiratorial Kickback Scheme Exponentially Increased Defendants’ Profits at the Expense of Plaintiff, its Plan Members and Other Payers Napoli Shkolnik has filed a lawsuit on behalf of…

  7. Big Molecule Watch

    Insulin Updates: March 2023

    By Beth Ashbridge

    On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program…

  8. Nonprofit Law Blog

    Nonprofit Tweets of the Week – 3/3/23

    By NEO Law Group

    Stay informed of the week’s notable events and shared resources with this curated list of Nonprofit Tweets of the Week. Notable Events of the Week: “Alone and Exploited, Migrant Children…

  9. Ogletree Deakins Insights

    New HDHP Insulin Safe Harbor Under Inflation Reduction Act of 2022

    By By: Kristine M. Bingman

    On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (IRA) (P.L. 117-169), a budget reconciliation act focused on tax reform, climate change, and healthcare…

  10. Take Stock: Federal Policy Watch

    Washington Healthcare Update | Mar. 21, 2022

    By Stephanie A. Kennan, Gina Sherick, McGuireWoods LLP

    This Week in Washington: President Biden Signs Omnibus Appropriations Package into Law to Fund the Federal Government Through FY 2022 Congress House Reps. Maloney, Pressley and Bush Call for Expansion…